Cypress Capital Management (Wyoming)’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-169
| Closed | -$36.8K | – | 214 |
|
|
2026
Q1 | $36.8K | Hold |
169
| – | – | 0.03% | 107 |
|
|
2025
Q4 | $38.6K | Hold |
169
| – | – | 0.04% | 96 |
|
|
2025
Q3 | $39.1K | Hold |
169
| – | – | 0.04% | 96 |
|
|
2025
Q2 | $31.4K | Hold |
169
| – | – | 0.03% | 101 |
|
|
2025
Q1 | $35.4K | Buy |
+169
| New | +$32.9K | 0.04% | 89 |
|
|
2021
Q3 | – | Sell |
-200
| Closed | -$23K | – | 239 |
|
|
2021
Q2 | $23K | Hold |
200
| – | – | 0.02% | 173 |
|
|
2021
Q1 | $22K | Hold |
200
| – | – | 0.02% | 166 |
|
|
2020
Q4 | $21K | Hold |
200
| – | – | 0.02% | 154 |
|
|
2020
Q3 | $18K | Hold |
200
| – | – | 0.02% | 138 |
|
|
2020
Q2 | $20K | Hold |
200
| – | – | 0.02% | 130 |
|
|
2020
Q1 | $15K | Sell |
200
-500
| -71% | -$42.6K | 0.02% | 115 |
|
|
2019
Q4 | $62K | Hold |
700
| – | – | 0.06% | 103 |
|
|
2019
Q3 | $53K | Sell |
700
-578
| -45% | -$39.6K | 0.06% | 98 |
|
|
2019
Q2 | $93K | Hold |
1,278
| – | – | 0.11% | 89 |
|
|
2019
Q1 | $103K | Hold |
1,278
| – | – | 0.14% | 80 |
|
|
2018
Q4 | $118K | Hold |
1,278
| – | – | 0.23% | 70 |
|
|
2018
Q3 | $121K | Buy |
1,278
+400
| +46% | +$37.9K | 0.12% | 111 |
|
|
2018
Q2 | $81K | Hold |
878
| – | – | 0.09% | 131 |
|
|
2018
Q1 | $83K | Buy |
878
+228
| +35% | +$25K | 0.1% | 119 |
|
|
2017
Q4 | $63K | Sell |
650
-650
| -50% | -$61.3K | 0.07% | 142 |
|
|
2017
Q3 | $116K | Sell |
1,300
-2,035
| -61% | -$155K | 0.14% | 100 |
|
|
2017
Q2 | $242K | Hold |
3,335
| – | – | 0.28% | 61 |
|
|
2017
Q1 | $217K | Hold |
3,335
| – | – | 0.27% | 62 |
|
|
2016
Q4 | $208K | Buy |
3,335
+1,500
| +82% | +$91.6K | 0.22% | 63 |
|
|
2016
Q3 | $116K | Hold |
1,835
| – | – | 0.15% | 81 |
|
|
2016
Q2 | $114K | Hold |
1,835
| – | – | 0.15% | 71 |
|
|
2016
Q1 | $105K | Hold |
1,835
| – | – | 0.14% | 80 |
|
|
2015
Q4 | $109K | Hold |
1,835
| – | – | 0.14% | 86 |
|
|
2015
Q3 | $99.8K | Hold |
1,835
| – | – | 0.13% | 85 |
|
|
2015
Q2 | $123K | Hold |
1,835
| – | – | 0.14% | 90 |
|
|
2015
Q1 | $107K | Hold |
1,835
| – | – | 0.13% | 92 |
|
|
2014
Q4 | $120K | Buy |
+1,835
| New | +$116K | 0.16% | 82 |
|
Other funds holding ABBV
Cypress Capital Management (Wyoming)'s ABBV Position: Q2 2026 in Review
Cypress Capital Management (Wyoming) sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 169 shares — an estimated $36.8K sold.
Cypress Capital Management (Wyoming) first reported a position in ABBV in Q4 2014 and held it in 32 quarters. The position peaked at $242K in Q2 2017. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Cypress Capital Management (Wyoming) reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
- Cypress Capital Management (Wyoming) sold 169 AbbVie shares in Q2 2026, an estimated $36.8K.
- Cypress Capital Management (Wyoming) first reported a position in AbbVie in Q4 2014 and held it in 32 quarters.
- Cypress Capital Management (Wyoming)'s AbbVie position peaked at $242K in Q2 2017.
- 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.